Hepatic insulin clearance is the primary determinant of insulin sensitivity in the normal dog

  • Marilyn Ader
    Diabetes and Obesity Research Institute Cedars‐Sinai Medical Center Los Angeles California
  • Darko Stefanovski
    Diabetes and Obesity Research Institute Cedars‐Sinai Medical Center Los Angeles California
  • Stella P. Kim
    Diabetes and Obesity Research Institute Cedars‐Sinai Medical Center Los Angeles California
  • Joyce M. Richey
    Diabetes and Obesity Research Institute Cedars‐Sinai Medical Center Los Angeles California
  • Viorica Ionut
    Diabetes and Obesity Research Institute Cedars‐Sinai Medical Center Los Angeles California
  • Karyn J. Catalano
    Diabetes and Obesity Research Institute Cedars‐Sinai Medical Center Los Angeles California
  • Katrin Hucking
    Diabetes and Obesity Research Institute Cedars‐Sinai Medical Center Los Angeles California
  • Martin Ellmerer
    Diabetes and Obesity Research Institute Cedars‐Sinai Medical Center Los Angeles California
  • Gregg Van Citters
    Diabetes and Obesity Research Institute Cedars‐Sinai Medical Center Los Angeles California
  • Isabel R. Hsu
    Diabetes and Obesity Research Institute Cedars‐Sinai Medical Center Los Angeles California
  • Jenny D. Chiu
    Diabetes and Obesity Research Institute Cedars‐Sinai Medical Center Los Angeles California
  • Orison O. Woolcott
    Diabetes and Obesity Research Institute Cedars‐Sinai Medical Center Los Angeles California
  • Lisa N. Harrison
    Diabetes and Obesity Research Institute Cedars‐Sinai Medical Center Los Angeles California
  • Dan Zheng
    Diabetes and Obesity Research Institute Cedars‐Sinai Medical Center Los Angeles California
  • Maya Lottati
    Diabetes and Obesity Research Institute Cedars‐Sinai Medical Center Los Angeles California
  • Cathryn M. Kolka
    Diabetes and Obesity Research Institute Cedars‐Sinai Medical Center Los Angeles California
  • Vahe Mooradian
    Diabetes and Obesity Research Institute Cedars‐Sinai Medical Center Los Angeles California
  • Justin Dittmann
    Diabetes and Obesity Research Institute Cedars‐Sinai Medical Center Los Angeles California
  • Sophia Yae
    Diabetes and Obesity Research Institute Cedars‐Sinai Medical Center Los Angeles California
  • Huiwen Liu
    Diabetes and Obesity Research Institute Cedars‐Sinai Medical Center Los Angeles California
  • Ana Valeria B. Castro
    Diabetes and Obesity Research Institute Cedars‐Sinai Medical Center Los Angeles California
  • Morvarid Kabir
    Diabetes and Obesity Research Institute Cedars‐Sinai Medical Center Los Angeles California
  • Richard N. Bergman
    Diabetes and Obesity Research Institute Cedars‐Sinai Medical Center Los Angeles California

書誌事項

公開日
2013-12-03
権利情報
  • http://onlinelibrary.wiley.com/termsAndConditions#vor
DOI
  • 10.1002/oby.20625
公開者
Wiley

この論文をさがす

説明

<jats:sec><jats:title>Objective</jats:title><jats:p>Insulin resistance is a powerful risk factor for Type 2 diabetes and a constellation of chronic diseases, and is most commonly associated with obesity. We examined if factors other than obesity are more substantial predictors of insulin sensitivity under baseline, nonstimulated conditions.</jats:p></jats:sec><jats:sec><jats:title>Methods</jats:title><jats:p>Metabolic assessment was performed in healthy dogs (<jats:italic>n</jats:italic> = 90). Whole‐body sensitivity from euglycemic clamps (SI<jats:sub>CLAMP</jats:sub>) was the primary outcome variable, and was measured independently by IVGTT (<jats:italic>n</jats:italic> = 36). Adiposity was measured by MRI (<jats:italic>n</jats:italic> = 90), and glucose‐stimulated insulin response was measured from hyperglycemic clamp or IVGTT (<jats:italic>n</jats:italic> = 86 and 36, respectively).</jats:p></jats:sec><jats:sec><jats:title>Results</jats:title><jats:p>SI<jats:sub>CLAMP</jats:sub> was highly variable (5.9‐75.9 dl/min per kg per μU/ml). Despite narrow range of body weight (mean, 28.7 ± 0.3 kg), adiposity varied approximately eight‐fold and was inversely correlated with SI<jats:sub>CLAMP</jats:sub> (<jats:italic>P</jats:italic> < 0.025). SI<jats:sub>CLAMP</jats:sub> was negatively associated with fasting insulin, but most strongly associated with insulin clearance. Clearance was the dominant factor associated with sensitivity (<jats:italic>r</jats:italic> = 0.53, <jats:italic>P</jats:italic> < 0.00001), whether calculated from clamp or IVGTT.</jats:p></jats:sec><jats:sec><jats:title>Conclusions</jats:title><jats:p>These data suggest that insulin clearance contributes substantially to insulin sensitivity, and may be pivotal in understanding the pathogenesis of insulin resistance. We propose the hyperinsulinemia due to reduction in insulin clearance is responsible for insulin resistance secondary to changes in body weight.</jats:p></jats:sec>

収録刊行物

  • Obesity

    Obesity 22 (5), 1238-1245, 2013-12-03

    Wiley

被引用文献 (1)*注記

もっと見る

詳細情報 詳細情報について

問題の指摘

ページトップへ